26 results on '"d'Alteroche L"'
Search Results
2. Short- and long-term evolution of the endoluminal diameter of underdilated stents in transjugular intrahepatic portosystemic shunt
3. Transplantation hépatique pour les patients atteints de glycogénose de type 3 : une série de 3 cas
4. Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis
5. Virological and clinical outcomes of patients with HDV-related compensated cirrhosis treated with Bulevirtide monotherapy for 96 weeks: a retrospective multicenter european study (SAVE-D)
6. Severity of hepatic fibrosis after Fontan operation is associated with early postoperative inferior vena cava pressure and time from surgery
7. SAT-005 - Transjugular intrahepatic portosystemic shunt before planned abdominal surgery in cirrhotic patients
8. GS-001 - A randomized trial of 6-month norfloxacin therapy in patients with Child-Pugh class C cirrhosis
9. PS018 - Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
10. FRI-483 - Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study
11. FRI-481 - Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt
12. P0210 : Combined partial splenic embolization (PSE) allows reducing transjugular intrahepatic portosystemic shunt (TIPS) diameter in hypersplenic cirrhotic patients: A pilot study
13. P0137 : Safety of boceprevir-based triple therapy in HCV cirrhotic patients awaiting liver transplantation. Analysis from a French multicenter, open-label study (ANRS HC29 bocepretransplant)
14. LP05 : Daclatasvir plus sofosbuvir with or without ribavirin in patients with HCV genotype 3 infection: Interim analysis of a french multicenter compassionate use program
15. O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study
16. G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort
17. JAK2 V617F is specifically associated with idiopathic splanchnic vein thrombosis
18. P1111 ANRS HC15 NRFI: LONG-TERM MAINTENANCE THERAPY WITH A COMBINATION OF RIBAVIRIN AND PEGYLATED INTERFERON IN CHRONIC HEPATITIS C. RESULTS OF A MULTICENTER RANDOMIZED CONTROLLED TRIAL
19. P693 NEUROLOGIC DISORDERS DURING HEV INFECTION IN NONIMMUNOCOMPROMISED PATIENTS
20. 581 THE PRESENCE OF A RIGHT ATRIUM–HEPATIC VEIN PRESSURE GRADIENT WORSENS THE PROGNOSIS OF CIRRHOTIC PATIENTS WITH PORTAL HYPERTENSION
21. Imputabilité avérée de la vancomycine dans une thrombopénie profonde : à propos d’un cas clinique
22. Épanchement péricardique révélateur d’une insuffisance cardiaque à débit élevé par carence en thiamine chez un adulte jeune
23. 101 COMPARATIVE STUDY OF HEMOSTASIS IN PERIPHERAL AND PORTAL BLOOD IN PATIENTS WITH CIRRHOSIS
24. Interet et apport de l’echo-doppler dans le suivi des tips (transjugular intrahepatic portosystemic shunt)
25. P.227 Natural history of hepatitis C in twenty patients detected at the early stage of infection
26. O.145 Changes in medical resource utilisation by subjects who are tested HCV seropositive during routine medical check-up (1994–2003)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.